Authors: Konecny, G Untch, M Arboleda, J Wilson, C Kahlert, S Boettcher, B Felber, M Beryt, M Lude, S Hepp, H Slamon, D Pegram, M

Citation: G. Konecny et al., HER-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer, CLIN CANC R, 7(8), 2001, pp. 2448-2457

Authors: Konecny, G Fritz, M Untch, M Lebeau, A Felber, M Lude, S Beryt, M Hepp, H Slamon, D Pegram, M

Citation: G. Konecny et al., HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer, BREAST CANC, 69(1), 2001, pp. 53-63

Authors: Konecny, G Untch, M Slamon, D Beryt, M Kahlert, S Felber, M Langer, E Lude, S Hepp, H Pegram, M

Citation: G. Konecny et al., Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples, BREAST CANC, 67(3), 2001, pp. 223-233

Authors: Konecny, G Crohns, C Pegram, M Felber, M Lude, S Kurbacher, C Cree, IA Hepp, H Untch, M

Citation: G. Konecny et al., Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer, GYNECOL ONC, 77(2), 2000, pp. 258-263